Due to the nature of cancer, readiness for risks in drug development is much higher here than it might be in other medical fields. Can digital health innovators learn anything from oncology medicines development?
Read More
The potential of AI are, in theory, huge. However, this is not a free technology and another open question is, will its use bring down costs or just increase healthcare expenditure. Looking at history, the latter is not impossible.
Read More
Data gathering is not a problem in COVID-19 race towards a reliable vaccine. The challenge is how to evaluate it, says Glen de Vries, Co-Founder and Co-CEO of Medidata. End of July Medidata started working with Moderna to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.
Read More
ClinicalTrials.gov currently lists 302,091 clinical studies in the US. It is impossible for patients and their doctors to be aware of all clinical trials an individual might be eligible for. The data issues surrounding clinical trials don’t end there: how can we rely on results of trials when studies with negative results often go unpublished? Various companies are creating platforms and solutions to address these issues.
Read More